Akanda is trading at $8.89 (7.1% down) after disclosing a Nasdaq deficiency notice and mounting concerns over the company's balance sheet.
- The company received a Nasdaq deficiency notice on June 16, 2026, regarding negative stockholders’ equity and a failure to meet alternative listing standards.
- Shares are reacting to significant delisting risks stemming from this ongoing issue.
- The micro-cap cannabis firm's decline is further exacerbated by a weak broader market backdrop.